Healthcare & Life Sciences
Abivax
Francewww.abivax.com/
Abivax is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 7 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2013
Founded
7
Investors
About Abivax
Abivax is a startup founded in 2013 based in France. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 7 investors associated with the company.
Abivax is a clinical-stage biotechnology company developing therapeutics that modulate the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate, obefazimod, is in Phase 3 clinical trials for ulcerative colitis and Phase 2 for Crohn's disease.
Explore Abivax's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.